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Abstract: The development of effective antidotes against organophosphates such as dichlorvos has been a persistent
challenge over the past decades. Therapy of organophosphate poisoning is based on the administration of atropine and
oxime as standard antidotes. The present study was undertaken to evaluate the ability of sodium bicarbonate to improve
protective effects of standard antidotes in rats poisoned with dichlorvos. The aim of this experiment was to establish the
correlation between protective effects and biochemical parameters relevant for acid-base status. In order to examine
the protective effect of both standard antidotes and their combinations, groups of experimental animals were poisoned
subcutaneously with increasing doses of dichlorvos. Immediately thereafter, rats were treated with atropine 10 mg/kg
intramuscularly, oximes 10 mg/kg intramuscularly and sodium bicarbonate 3 mmol/kg intraperitoneally. These antidotes
were administered either as single doses or in combinations. In the biochemical part of the experiments, rats were poisoned
with dichlorvos 1.3 LD50 (10.64 mg/kg) subcutaneously and immediately thereafter treated with atropine 10 mg/kg intra-
muscularly, oximes (trimedoxime or obidoxime) 10 mg/kg intramuscularly and sodium bicarbonate 3 mmol/kg intraperito-
neally either as single doses or in combinations. Parameters relevant for acid-base status were measured 10 minutes after
the administration of antidotes. The results of our study indicate that addition of sodium bicarbonate to standard anti-
dotes significantly improves protective effects of atropine, obidoxime and trimedoxime. Correlation between protection
and biochemical outcome is clearly evident when sodium bicarbonate is being added to atropine.
Development of effective antidotes against organophos-
phates such as dichlorvos has been a persistent challenge
during the past decades. Characteristic signs and symptoms
of acute organophosphate intoxication are generally
thought to arise from the inhibition of acetylcholinesterase
(AChE, EC 3.1.1.7) and the ensuing acute cholinergic crisis.
Within the spectrum of pathophysiological changes result-
ing from acute organophosphate intoxication, ventilatory
insufficiency clearly represents the most life-threatening ele-
ment of their toxicity. Organophosphate-induced venti-
latory insufficiency is manifested as: (a) an increased airway
resistance and obstruction caused by combined broncho-
constriction (the so-called pulmonary muscarinic syn-
drome), and excessive mucus secretion, (b) depolarisation
neuromuscular blockade of respiratory-related muscu-
lature, and (c) failure of central respiratory drive (Adler et
al. 1992; Karalliedde & Henry 2001).
Therapy of organophosphate poisoning is based on the
administration of atropine and oximes as standard anti-
dotes (Willems & Belpaire 1992; Karalliedde & Szinicz
2001). Atropine effectively antagonises the muscarinic ac-
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tions of acetylcholine excess (increased tracheobronchial se-
cretions, bradycardia, salivation, bronchoconstriction).
However, it is well known that atropine does not have effect
on nicotinic receptor sites.
Oximes are well recognised as reactivators of inhibited
AChE (Bismuth 1992; Worek et al. 1996, 1997 & 2004; Thi-
ermann et al. 1999). Until today, oxime which possesses
properties of ‘‘universal’’ AChE reactivator has not been
synthesised. Therefore, oximes are not equally effective in
antagonising the toxicity of structurally different organo-
phosphates. It has been shown that among the currently
used oximes trimedoxime (1,3-bis-(4-hydroxyiminomethyl-
pyridinium)-1-propane dichloride) and obidoxime (bis-(4-
hydroxyiminomethyl-pyridinium)-1-methylether dichloride)
are very efficient antidotes in poisonings caused by the ma-
jority of OP insecticides (Jokanovic & Maksimovic 1995;
Worek et al. 1996; Antonijevic et al. 2005). Despite the fact
that effects of organophosphates were extensively investi-
gated and well documented, there is still a wide range of
problems concerning therapeutic approaches to the organo-
phosphate poisoning.
During the last few years further improvement of the
therapy was also made with the introduction of sodium bi-
carbonate (NaHCO3). It has been reported that administra-
tion of NaHCO3 potentates therapeutic activity of atropine
in acute organophosphate poisonings. According to the
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clinical findings, Balali-Mood et al. (2000 & 2002) con-
cluded that NaHCO3 could be useful as a part of thera-
peutic regimen in human organophosphate poisoning.
The present study was undertaken to evaluate the ability
of NaHCO3 to improve protective effects of standard anti-
dotes in rats poisoned with dichlorvos. The aim of this trial
was also to investigate the possible correlation between the
protective effects and the biochemical parameters relevant
for acid-base status.
Materials and Methods
Chemicals. Dichlorvos (2,2-dichlorovinyldimethylphosphate) was
purchased from CIBA, Basel, Switzerland. Trimedoxime and obi-
doxime were obtained from the Military Technical Institute, Belgra-
de, Serbia and Montenegro. The purity of the oximes was analysed
by HPLC technique and it was greater than 99%. Atropine was
purchased from Sigma Chemical Company, St. Louis, MO, USA.
All the other chemicals of analytical grade were purchased from
commercial sources. Stock solution of dichlorvos was prepared in
isopropanol. Oximes were dissolved in distilled water and diluted to
the required concentration immediately before use.
Animal experiments. Males Wistar rats (180–240 g) were obtained
from the Military Medical Academy, Belgrade, Serbia and
Montenegro. The animals were acclimatised for at least one week
prior to use and received food and tap water ad libitum.
The study protocol was based on the Guidelines for Animal
Study no. 282–12/2002 (Ethics Committee of the Military Medical
Academy, Belgrade, Serbia and Montenegro).
Protection. In order to examine the protective effect of antidote(s),
five groups of experimental animals (nΩ8 per group) were poisoned
subcutaneously with increasing doses of dichlorvos. Immediately
thereafter rats were treated with atropine 10 mg/kg intramuscularly,
oximes 10 mg/kg intramuscularly and NaHCO3 3 mmol/kg intra-
peritoneally. These antidotes were administered either as single
doses or in combinations. After the 24 hr survival registration, me-
dian lethal doses (LD50) were calculated according to the method
of Litchfield & Wilcoxon (1949), with 95% confidence limits. Pro-
tective indices were calculated according to the following equation:
Protective indices (antidote) Ω
LD50 (dichlorvosπantidote)
LD50 (dichlorvos)
Biochemistry. The biochemical experiments were divided into two
parts. In the first part of the experiments, aimed to find out the
optimal time interval relevant for the assessment of biochemical
parameters, arterial blood samples were collected 10, 20 and 30
min. after the administration of NaHCO3 3 mmol/kg intraperito-
neally.
Within the second part of the biochemical experiments, when the
time period between the application of tested substances and ar-
terial blood sampling was fixed at 10 min., rats were poisoned with
dichlorvos 1.3 LD50 (10.64 mg/kg) subcutaneously and immediately
thereafter treated with atropine 10 mg/kg intramuscularly, oximes
(trimedoxime, obidoxime) 10 mg/kg intramuscularly and NaHCO3
3 mmol/kg intraperitoneally either as single doses or in combi-
nations. In the biochemical sets of experiments partial pressure of
oxygen, partial pressure of carbon dioxide, total CO2 content, base
excess, standard bicarbonate, base excess in extracellular fluids,
oxygen saturation calculated at a normal p50 (p50 is the oxygen
tension at half saturation of blood), pH and concentration of bicar-
bonate anion (HCO3ª) in arterial blood were measured by the
Blood Gas Analyser – BGM (model IL 1312), Instrumentation
Laboratory, Lexington, USA. Arterial blood samples were drawn
by intracardial puncture using heparinised syringe and kept on ice
until analysing.
Data analysis. Statistical significance was determined by means of
Student’s t-test and Mann-Whitney U-test, and differences were
considered significant when P0.05, P0.01 and P0.001.
Results
Protection. Co-administration of NaHCO3 significantly in-
creased the protective effects of standard antidotes given
alone in rats poisoned with dichlorvos (fig. 1). Addition of
bicarbonate increased protective indices of atropine, trime-
Fig. 1. Protective indices of antidotes and their combinations in rats
poisoned by dichlorvos (DDVP). NaHCO3 (3 mmol/kg intraperito-
neally), atropine (ATR) (10 mg/kg intramuscularly), trimedoxime
(TMB-4) (10 mg/kg intramuscularly) and obidoxime (Lu¨H) (10 mg/
kg intramuscularly) were given immediately after the increasing
doses of DDVP (subcutaneously).
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Table 1.
pO2* and pCO2* in the arterial blood samples of non-poisoned rats treated by NaHCO3 (3 mmol/kg intraperitoneally), during 30 min. after
administration (mean∫S.D.).
Time after
administration (min) pH HCO3ª (mmol/l) pO2 (kPa) pCO2 (kPa)
0 7.43∫0.03 22.40∫2.12 15.10∫4.66 4.46∫0.59
10 7.47∫0.08 29.80∫2.96b 9.42∫2.71a 5.40∫0.82
20 7.44∫0.04 26.87∫3.71a 9.81∫3.03a 5.22∫1.02
30 7.44∫0.03 25.03∫2.83 11.68∫0.78 4.82∫0.30
aP0.05 versus 0 min.
bP0.001 versus 0 min.
*Abbreviations: HCO3ª: concentration of bicarbonate anion, pO2: partial pressure of oxygen, pCO2: partial pressure of carbon dioxide.
doxime and obidoxime by 1.72, 2.27 and 2.07 times, respec-
tively. Obidoxime given alone provided better protection of
experimental animals than trimedoxime, i.e. protective in-
dice value of obidoxime was 2.59 times greater than that of
trimedoxime.
Effects of sodium bicarbonate. In the first part of biochem-
ical experiments, maximal changes were obtained 10 min.
after the administration of NaHCO3 (tables 1 & 2). During
the biochemical experiment, blood gas partial pressure of
oxygen value decreased significantly from the saline group
and caused the fall in oxygen saturation value. Expectedly,
Table 2.
Acid-base status parameters in the arterial blood samples of non-poisoned rats treated by NaHCO3 (3 mmol/kg intraperitoneally) during
30 min. time period after administration (mean∫S.D.).
Time after
administration (min.) ct CO2* (mmol/l) BEb* (mmol/l) SBC* (mmol/l) BEecf* (mmol/l) sO2c* (%)
0 23.45∫2.24 ª0.56∫1.74 24.46∫1.36 ª2.06∫2.07 97.83∫1.48
10 31.06∫2.93a2 6.24∫3.78a1 29.64∫3.01a1 6.00∫3.89a1 92.50∫5.93
20 28.10∫3.89a 3.25∫2.82a 27.28∫2.17a 2.55∫3.59a 91.28∫10.90
30 26.13∫2.89 1.76∫2.91 26.26∫2.28 0.71∫3.29 96.96∫0.49
a, a1, a2P0.05, 0.01, 0.001 versus 0 min.
* Abbreviations: ct CO2: total CO2 content, BEb: base excess, SBC: standard bicarbonate, BEecf: base excess in extra-cellular fluids, sO2c:
oxygen saturation calculated at a normal p50 (p50 is the oxygen tension at half saturation of blood) in arterial blood.
Table 3.
Values (mean∫S.D.) of pH, bicarbonate (HCO3ª), partial pressure of oxygen (pO2) and carbon dioxide (pCO2) in the arterial blood of rats
10 min after poisoning with 1.3 LD50 of dichlorvos (DDVP) (10.64 mg/kg subcutaneously) and treatment with atropine (10 mg/kg intramus-
cularly), trimedoxime (TMB-4)/obidoxime (LüH-6) (10 mg/kg intramuscularly) and NaHCO3 (3 mmol/kg intraperitoneally).
Treatment pH HCO3ª (mmol/l) pO2 (kPa) pCO2 (kPa)
Saline 7.43∫0.03 22.40∫2.12 15.02∫4.34 4.52∫0.61
NaHCO3 7.47∫0.08 29.80∫2.96a2,b1 9.42∫2.71a 5.40∫0.82
DDVP 7.11∫0.02a 23.15∫2.12 2.73∫2.87a1 10.28∫4.24a2
DDVPπatropine 7.14∫0.18 22.48∫4.11 3.33∫2.37a1 9.08∫3.35a2
DDVPπatropineπNaHCO3 7.39∫0.07b1,c 26.92∫2.75a1,b,c 6.20∫3.88a 5.98∫1.21a1,b
DDVPπTMB-4 7.35∫0.07a,b 18.55∫4.12b 10.26∫4.42b2 4.47∫1.21b2
DDVPπTMB-4πNaHCO3 7.38∫0.13b 20.28∫4.38 11.16∫3.15b2 5.36∫1.39b
DDVPπLüH-6 7.33∫0.09a,b 15.88∫1.54a2,b2 10.82∫4.62b1 4.06∫0.95b
DDVPπLüH-6πNaHCO3 7.37∫0.15b 19.75∫3.55d 12.81∫2.32b2 4.50∫1.08b1
a,a1,a2P0.05, 0.01, 0.001 significantly different from the saline group.
b,b1,b2P0.05, 0.01, 0.001 significantly different from DDVP group.
cP0.05 significantly different from DDVPπatropine group.
dP0.05 significantly different from DDVPπLüH-6 group.
the partial pressure of carbon dioxide value increased, as
well as total CO2 content. Compared to the control groups,
the values of the base excess and the base excess in extracel-
lular fluids were significantly higher during the 20 min.
period after the administration of NaHCO3. Elevation in
standard bicarbonate value was also present and signifi-
cantly different from saline group in the first two time-
points observed.
Effects of dichlorvos. Since there was a statistically signifi-
cant difference in blood partial pressure of oxygen and par-
tial pressure of CO2 values between dichlorvos-treated rats
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Table 4.
Acid-base status parameters (mean∫S.D.) in the arterial blood of rats 10 min. after poisoning with 1.3 LD50 dichlorvos (DDVP) (10.64 mg/
kg subcutaneously) and treatment with atropine (10 mg/kg intramuscularly) and NaHCO3 (3 mmol/kg intraperitoneally).
Treatment ct CO2* (mmol/l) BEb* (mmol/l) SBC* (mmol/l) BEecf* (mmol/l) sO2c* (%)
Saline 23.08∫2.19 ª0.52∫1.86 24.98∫1.30 ª2.16∫2.01 98.65∫1.62
NaHCO3 31.06∫2.93a2 6.24∫3.78a1 29.64∫3.01a1 6.00∫3.89a1 92.50∫5.93
DDVP 25.51∫2.01 ª7.25∫5.50a 17.31∫5.11a1 ª6.53∫4.57 31.00∫37.34a1
DDVPπatropine 24.60∫3.99 ª7.13∫6.80a 17.63∫5.79a ª6.71∫6.44 38.05∫29.59a2
DDVPπatropineπNaHCO3 28.30∫2.93a1 2.05∫2.4b1,c 25.71∫1.81b1,c1 1.71∫2.78a,b1,c 69.88∫14.49a2,b,c
a,a1,a2P0.05, 0.01, 0.001 significantly different from the saline group.
b,b1P0.05, 0.01 significantly different from DDVP group.
c,c1P0.05, 0.01 significantly different from DDVPπatropine group.
* Abbreviations: ct CO2: total CO2 content, BEb: base excess, SBC: standard bicarbonate, BEecf: base excess in extra-cellular fluids, sO2c:
oxygen saturation calculated at a normal p50 (p50 is the oxygen tension at half saturation of blood) in arterial blood.
and saline group, a shift in oxygen calculated value from
98.65% to 31.00% was expected (table 3). Depletion of both
the base excess and the base excess in extra-cellular fluids
was also present (table 4).
Effects of sodium bicarbonate and atropine in dichlorvos-
poisoned rats. Introduction of atropine had no influence on
tested biochemical parameters in rats poisoned with DDVP
(tables 3 & 4). Addition of NaHCO3 to atropine induced
statistically significant correction in partial pressure of CO2
value. Much better results were developed for four par-
ameters: oxygen saturation, base excess, standard bicarbon-
ate and base excess in extracellular fluid.
Effects of sodium bicarbonate and oximes in dichlorvos-
poisoned rats. Introduction of trimedoxime and obidoxime
as single doses or with sodium bicarbonate significantly in-
creased values of arterial blood (tables 3 & 5). Co-adminis-
tration of NaHCO3 to obidoxime produced statistically sig-
nificant improvement in total CO2 content. However, no
statistically significant improvement could be seen when the
following three parameters were evaluated: base excess,
standard bicarbonate, base excess in extracellular fluids, al-
though addition of NaHCO3 improved base excess and base
Table 5.
Acid-base status parameters (mean∫S.D.) in the arterial blood of rats 10 min. after poisoning with 1.3 LD50 dichlorvos (DDVP) (10.64 mg/
kg subcutaneously) and treatment with trimedoxime (TMB-4) or obidoxime (LüH-6) (10 mg/kg intramuscularly) and NaHCO3 (3 mmol/kg
intraperitoneally).
Treatment ct CO2* (mmol/l) BEb* (mmol/l) SBC* (mmol/l) BEecf* (mmol/l) sO2c* (%)
Saline 23.08∫2.19 ª0.52∫1.86 24.98∫1.30 ª2.16∫2.01 98.65∫1.62
NaHCO3 31.06∫2.93a2 6.24∫3.78a1 29.64∫3.01a1 6.00∫3.89a1 92.50∫5.93
DDVP 25.51∫2.01 ª7.25∫5.50a 17.31∫5.11a1 ª6.53∫4.57 31.00∫37.34a1
DDVPπTMB-4 19.58∫4.39b ª5.46∫3.73a 20.35∫2.77a1 ª7.23∫4.34a 87.48∫14.28b1
DDVPπTMB-4πNaHCO3 21.50∫4.48 ª4.98∫5.37 20.75∫4.10 ª6.16∫5.55 87.88∫6.38a1,b1
DDVPπLüH-6 16.82∫1.59a2,b2 ª8.12∫2.54a2 18.32∫2.18a2 ª10.28∫2.31a2 88.42∫13.61b1
DDVPπLüH-6πNaHCO3 20.80∫3.38b,c ª3.98∫5.96 21.76∫4.72 ª5.66∫5.75 96.25∫3.88b1
a,a1,a2P0.05, 0.01, 0.001 significantly different from the saline group.
b,b1,b2P0.05, 0.01, 0.001 significantly different from DDVP group.
cP0.05 significantly different from DDVPπLüH-6 group.
* Abbreviations: ct CO2: total CO2 content, BEb: base excess, SBC: standard bicarbonate, BEecf: base excess in extra-cellular fluids, sO2c:
oxygen saturation calculated at a normal p50 (p50 is the oxygen tension at half saturation of blood) in arterial blood.
excess in extracellular fluids values obtained when obidoxi-
me was given alone (table 5).
Discussion
Since the NaHCO3-induced improvement in protective ef-
fects of of atropine and oximes in rats poisoned with
dichlorvos could not be attributed to the increase in the
AChE activity neither in brain, nor in the respiratory
muscles (Antonijevic et al. 2002), our assumption was that
this benefitial effect could be ascribed to mere correction of
the respiratory acidosis, caused by combined central and
peripheral effects of dichlorvos.
In the present paper co-administration of sodium bicar-
bonate improved significantly protective effects of atropine,
trimedoxime and obidoxime used in rats poisoned with
dichlorvos and this result confirms the similar findings re-
ported by the other authors.
So far, it has been reported that administration of NaH-
CO3 potentiates therapeutic activity of atropine in acute or-
ganophosphate poisonings (Balali-Mood et al. 2000 &
2002; Bajgar & Portmann 2001; Karalliedde & Szinicz
2001). Animal studies on this topic have suggested that
NaHCO3 therapy decreased the rate of mortality in organo-
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phosphate poisonings (Cordoba et al. 1983; Wong et al.
1998; Bajgar & Portmann 2001). Bajgar & Portmann (2001)
examined the potential beneficial role of NaHCO3 (3 mmol/
kg intraperitoneally) in rats intoxicated with 2 LD50 subcu-
taneously of sarin, dichlorvos or pyridostigmine and re-
ported that administration of NaHCO3 had a therapeutic
effect in organophosphate and pyridostigmine intoxication,
even more so when combined with atropine. In the study
published by Balali-Mood et al. (2000), patients with diag-
nosed organophosphate poisonings (mainly suicidal) were
treated intravenously with atropine plus NaHCO3 (3 meq./
kg over one hour, followed by 3 meq./kg in 1 l of dextrose
per day until recovery/death). According to the clinical
findings, these authors concluded that NaHCO3 could be
useful as a part of therapeutic regimen in human organo-
phosphate poisoning. Another study of the same group of
authors showed that infusion of high doses of NaHCO3 (5
meq./kg during 30 min., followed by 5–6 meq./kg/day to
obtain a pH in the arterial blood of around 7.5) was effec-
tive and significantly decreased the total atropine dose used
in the treatment of patients with organophosphate pesticide
poisoning (Balali-Mood et al. 2002). However, in the papers
cited, there was no evidence/explanation about the underly-
ing mechanism(s) of beneficial action of NaHCO3.
Early findings on this topic (Jeevarathinam et al. 1988)
demonstrated that NaHCO3 pretreatment in rats poisoned
with diisopropyl fluorophosphate significantly enhanced the
therapeutic efficacy of pralidoxime chloride, with an in-
crease of protective indices from 7.63 to 11.7. In order to
explain the mode of action of NaHCO3, the same authors
also investigated pharmacokinetic properties of pralidoxi-
me, showing that bicarbonate application led to a signifi-
cant increase in oxime distribution into the tissue compart-
ment.
In our previously published study (Antonijevic et al.
2002), where standard antidotes were given along with
NaHCO3 in rats poisoned with 0.75 LD50 of dichlorvos,
brain, diaphragmal and erythrocyte AChE activities were
evaluated. Concerning the results of Jeevarathinam et al.
(1988), it was expected to obtain better reactivation of the
inhibited AChE in target tissues. However, introduction of
NaHCO3 increased neither the trimedoxime- nor obidoxime
reactivating effects. Therefore, in the present study, we made
an attempt to further explain the improvement of the pro-
tective effects of all three antidotes obtained by their co-
administration with sodium bicarbonate, through analysis
of the biochemical parameters that are relevant for the as-
sessment of the acid-base status.
If we briefly summarise our current results, there are sev-
eral important findings worthy of being pointed out and
discussed in view of the other available publications.
First, administration of bicarbonates to non-poisoned
rats does not result in change of the pH of arterial blood
and partial pressure of CO2 levels but, especially 10 min.
after bicarbonate administration, significantly increases the
bicarbonate content of the blood, total CO2 content, stan-
dard bicarbonate and base excess in blood and extracellular
fluid and decreases the partial pressure of O2 values, a find-
ing that matches the description of metabolic alkalosis.
Experiments in bigger animals, like cats, in whom a
larger quantity of NaHCO3 can be administered (7 mmol/
kg), such a metabolic alkalosis led also to the decrease in
the partial O2 pressure and increase in the partial pressure
of CO2, but these changes were accompanied by an increase
in the arterial blood pH, from 7.383, to 7.650. The pro-
posed mechanism was that the increased arterial pH caused
a decrease in chemoreceptor activity, thus rendering this
feed-back mechanism less susceptible to hypercapnia (Po-
korski & Lahiri 1982). This mechanism can explain the in-
crease in partial pressure of CO2 in non-poisoned rats in-
jected with NaHCO3.
Second, intoxication with dichlorvos leads to a severe
respiratory acidosis, characterised by pH of 7.11, almost a
6 times decrease in partial pressure of O2, a drop 3 times in
oxygen saturation, doubling of partial pressure of CO2 and
a big base and bicarbonate deficit. These findings are con-
sistent with respiratory failure, shown by (Takahashi et al.
1991).
Experiments in goats with intravenous injection of a
sublethal dose of dichlorvos have shown that, in the absence
of hypersecretion of saliva and nasal discharge, the respir-
atory distress developed, characterised by an increase in the
total pulmonary resistance and skeletal muscle faciculations
could be explained by the overstimulation of bronchial
smooth muscle muscarinic and myoneural nicotinic recep-
tors, respectively. In three out of five animals even a post-
inspiratory pause was noted, suggesting the impairment of
the central respiratory drive. Due to the low dose of
dichlorvos used, these changes did not result in significant
changes of minute ventilation and arterial oxygen and car-
bon dioxide partial pressures (Bakima et al. 1989).
An additional proof to the fact that a dose of dichlorvos
sufficiently high to induce the detrimental respiratory ef-
fects is the experimental study performed in German shep-
herd dogs, where dichlorvos 60 mg/kg orally failed to cause
any cholinergic symptoms, although the erythrocyte acetyl-
cholinesterase activity was inhibited by 43.7% (Dellinger et
al. 1987).
Respiratory failure, following acute exposure to organo-
phosphate anticholinesterase agents has been well studied.
Rickett et al. (1986) examined the effects of the nerve
agents, soman, sarin, tabun and VX on diaphragm contrac-
tion, diaphragm electromyogram, phrenic nerve activity,
medullary respiratory-related unit activity and airflow in
the cat. They concluded that the loss of central respiratory
drive was the predominant cause of the nerve agent-induced
respiratory failure. Soman-induced respiratory failure in
awake, non-anaethetised guinea pigs has been investigated
by Chang et al. (1990). Respiratory response to soman typ-
ically begins with hyperpnoea, which is followed by dys-
pnoea, hypopnoea and finally respiratory failure. Another
study has been conducted by using guinea-pigs in sarin poi-
soning (Taysse et al. 2003). The results have shown that
respiratory distress was revealed by a significant decrease in
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minute ventilation, tidal volume and frequency rate due to
an apnoeic state. Worek et al. (1994a & 1995) reported that
VX and sarin poisoning caused a rapid respiratory arrest
in a guinea-pig model.
Using domestic pigs percutaneously exposed to VX, at
the time of apnoea, Chilcott et al. (2003) demonstrated stat-
istically significant elevation in Kπ, inorganic phosphates,
partial pressure of CO2 and partial pressure of CO2, as well
as the decrease in arterial blood pH. In the same study
value of HCO3ª remained unchanged. In the study pub-
lished by Peng et al. (2004), aimed to assess the efficacy of
haemoperfusion in the treatment of the patients with acute
severe dichlorvos poisoning, respiratory failure was diag-
nosed as respiratory distress, hypoventilation (partial press-
ure of O2 of 60 mmHg, partial pressure of CO245
mmHg) accompanied by acidaemia (pH7.30).
The aforementioned respiratory distress induced by the
organophosphates is a sum of the central and peripheral
cholinergic effects, the former consisting of impairment
and, finally, loss of the respiratory drive and the latter com-
prising the so-called ‘‘pulmonary muscarinic syndrome’’ (la-
ryngospasm, bronchospasm and bronchorrhoea) and the
depolarisational nicotinic receptor-mediated respiratory
skeletal muscle blockade (Rivet & Potgieter 1987; van Held-
en et al. 1996; Chatonnet et al. 2003). It seems that the
muscarinic receptors responsible for central nervous system
effects, including the impairment of the respiratory centre,
belong to the M2 subtype, while the ones, whose hyper-
stimulation is responsible for the bronchial symptoma-
tology, are identified as M1 subtype (Maynard & Beswick
1992).
Third, bicarbonates significantly increased the protective
indices of atropine, trimedoxime and obidoxime monother-
apeutic regimens in dichlorvos intoxication, but failed to
add some more protection to atropine π oxime combi-
nations. It is well known that atropine can protect experi-
mental animals exposed to various incapacitating or lethal
doses of dichlorvos (Savic et al. 2003). Effectiveness of atro-
pinisation was also proven in human beings poisoned with
dichlorvos (Singh et al. 2001).
It seems that atropine, being both centrally and periph-
erally acting antimuscarinic drug, is especially important in
antagonising the central effects of dichlorvos, since it was
shown that only atropine and not only peripherallyacting
antimuscarinic drugs glycopyrrolate or ipratropium bro-
mide pre-treatment can protect rats from the death 10 min.
following intoxication with dichlorvos (Bird et al. 2003;
Dickson et al. 2003).
It is, however, evident that the peripheral component of
the toxicity of dichlorvos in our experiment was also im-
portant, since the bispyridinium oxime obidoxime, known
for its limited passage through the blood-brain barrier into
the brain, also exerted an efficient protection against
dichlorvos-induced lethality in our previous and current ex-
periments (Antonijevic et al. 2002; Stefanovic et al. 2004).
These effects should be ascribed to their reactivating poten-
cies, proven in several species poisoned with dichlorvos
(Gyrd-Hansen & Kraul 1984). It was even shown in vitro
that obidoxime is more effective than 2-PAM, HI-6 and
HLö-7 in reactivation of human erythrocyte AChE inhib-
ited with dichlorvos (Worek et al. 1996).
Fourth, although offering some protection in survival of
rats intoxicated with dichlorvos, atropine treatment failed to
correct the dichlorvos-induced respiratory acidosis. This
finding contrasts the results of an experimental study, per-
formed in calves, where atropine, promptly and completely,
antagonised the decreased pulmonary compliance and ar-
terial oxygen tension and increased total pulmonary re-
sistance (Lekeux et al. 1986). Similar results were obtained
after treatment of dichlorvos-poisoned goats with atropine,
which could not antagonise only the central nervous symp-
toms and skeletal muscle fasciculations (Bakima et al. 1989).
The explanation for these discrepancies is the different
dose of dichlorvos used, the one in our experiment being
larger than in the others. Part of the explanation could also
be the various doses of atropine and different animal used
in these experiments. In accordance with these assumptions
are the results of the experimental study performed in
guinea-pigs, where atropine 10 mg/kg intravenously could
antagonise the respiratory failure caused by tabun 60 mg/kg
intravenously, but was ineffective against 300 mg/kg intra-
venously of tabun (Worek et al. 1994b).
Fifth, addition of bicarbonate to atropine, but even more
oxime monotherapies, corrected the dichlorvos-induced
respiratory acidosis. In case of the atropineπNaHCO3
combination, the result mentioned could be explained by
the additive muscarinic-blockig action of atropine and the
blood acidity-neautralising action of NaHCO3. In addition,
it was shown in man that the intravenous injection of
NaHCO3 can induce a significant increase in the cerebro-
spinal fluid partial pressure of O2 (Ryba & Pokorski 1981).
As mentioned before, the bispyridinium oximes trime-
doxime and obidoxime can reactivate practically only the
dichlorvos-inhbited AChE outside of the brain, i.e. the pe-
ripheral AChE, due to their extremely limited access to the
CNS. This finding was confirmed in our previous experi-
ments, where trimedoxime and obidoxime effectively react-
ivated erythrocyte and diaphragmal AChE, but failed to
reactivate brain AChE in rats poisoned with 0.75 LD50 of
dichlorvos (Antonijevic et al. 2002).
Logical explanation of the aforementioned efficacy of the
oximes in correcting the dichlorvos-induced arterial blood
gas impairment would be that reactivation of the peripheral
AChE alleviates the toxic effects of dichlorvos on respir-
atory muscles and lungs.
Sixth, addition of bicarbonate to atropine plus oxime
therapeutic regimen failed to afford extra protection and
did not further add to the correction of biochemical respir-
atory parameters. It is to be assumed that the atropine π
trimedoxime or obidoxime combinations were sufficiently
effective to antagonise the respiratory-impairments caused
by 1.3 LD50 of dichlorvos. Poisonings with larger doses of
dichlorvos, however, might require the use of NaHCO3, as
well.
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Possibly new insight into the problem of the mechanism
of toxic effects of the organophosphates on respiration and
of the mechanism of antidotal action of the oximes may
have recently been produced by monitoring the respiratory
function in wild-type and AChE-knock-out mice, lacking
all (homozygotes) or half of the usual AChE activity (het-
erozygotes). It was concluded that butyrylcholinesterase
might also play a significant role in the respiratory toxicity
of organophosphates (Boudinot et al. 2005).
Based on the results presented in this paper it is evident
that administration of NaHCO3 improved antidotal effects
of oximes and atropine, and that clear correlation between
protection and tested biochemical parameters has been ob-
tained only when sodium bicarbonate was added along with
atropine.
The beneficial role of NaHCO3 is a result of complex
biochemical reactions focused on compensation of acidosis
induced by severe organophosphate poisoning. Addition-
ally, alkalinisation of the blood with sodium bicarbonate
might increase the hydrolysis of the esteratic portion of or-
ganophosphate molecule, thus decreasing its toxicity (Kar-
alliedde & Szinicz 2001).
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